td-4208
Showing 1 - 9 of 9
Hepatic Impairment Trial in Orlando (TD-4208)
Completed
- Hepatic Impairment
- TD-4208
-
Orlando, FloridaOrlando Clinical Research Center (OCRD)
Feb 22, 2022
Renal Impairment Trial in Orlando (TD-4208)
Completed
- Renal Impairment
- TD-4208
-
Orlando, FloridaOrlando Clinical Research Center (OCRC)
Feb 22, 2022
COPD (COPD) Trial in Lincoln (TD-4208)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- TD-4208
-
Lincoln, NebraskaCelerion
Feb 22, 2022
COPD Trial in Greenville (TD-4208, Placebo)
Completed
- COPD
- TD-4208
- Placebo
-
Greenville, South CarolinaUpstate Pharmaceutical Research
Feb 22, 2022
COPD (COPD) Trial in Portland (TD-4208, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- TD-4208
- Placebo
-
Portland, OregonAllergy Associates Research Center (AARC)
Feb 22, 2022
COPD (COPD) Trial in Easley (TD-4208, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- TD-4208
- Placebo
-
Easley, South CarolinaPalmetto Medical Research Associates L.L.C.
Feb 22, 2022
COPD (COPD) Trial in Easley (TD-4208, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- TD-4208
- Tiotropium
-
Easley, South CarolinaPalmetto Medical Research Associates L.L.C
Feb 22, 2022
COPD, COPD Trial in Charlotte (TD-4208, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- COPD
- TD-4208
- Placebo
-
Charlotte, North CarolinaAmerican Health Research
Feb 22, 2022